Skip to main content
National Patient Survey 2024 logo.Our National Patient Survey 2024 report is now live. Thank you to all those that shared their experiences. Read our report here.

PGT-M conditions

The page below lists all PGT-M conditions currently authorised and awaiting consideration by the HFEA.

When publishing genetic conditions on the authorised list, we aim to be as consistent as possible with the OMIM database. However, many conditions may have several different names and we would recommend searching the list using the OMIM number for the condition as this is less likely to change throughout time.

If a condition does not appear on the list, it does not necessarily mean the condition has specifically not been authorised, it may mean that we have never before received an application from a UK centre to perform PGT-M for this condition and it has therefore never been considered by the HFEA.

Please note that we are always processing new applications to add genetic conditions to the list from UK centres licensed to perform PGT-M. This may mean that some authorised conditions may not be displayed. If you are unsure if a condition has been authorised or not, or would like any further information please contact the PGTM team at pgtm@hfea.gov.uk.

Click here for a downloadable list: approved condition list. Please note that the website page below is updated more regularly and is therefore more accurate than the downloadable list.

Condition name Status OMIM number Documents
Muscular Dystrophy, Limb-Girdle, Autosomal Recessive 18 (LGMDR18) approved 615356
Muscular Dystrophy, Limb-Girdle, Autosomal Recessive 5 (LGMDR5) approved 253700
Muscular Dystrophy-Dystroglycanopathy (Congenital with Brain and Eye Anomalies), Type A, 1 (MDDGA1) approved 236670
Muscular Dystrophy-Dystroglycanopathy (Congenital with Brain and Eye Anomalies), Type A, 10 (MDDGA10) approved 615041
Muscular Dystrophy-Dystroglycanopathy (Congenital with Brain and Eye Anomalies), Type A, 11 (MDDGA11) approved 615181
Muscular Dystrophy-Dystroglycanopathy (Congenital with Brain and Eye Anomalies), Type A, 12 (MDDGA12) approved 615249
Muscular Dystrophy-Dystroglycanopathy (Congenital with Brain and Eye Anomalies), Type A, 13 (MDDGA13) approved 615287
Muscular Dystrophy-Dystroglycanopathy (Congenital with Brain and Eye Anomalies), Type A, 14 (MDDGA14) approved 615350
Muscular Dystrophy-Dystroglycanopathy (Congenital with Brain and Eye Anomalies), Type A, 2 (MDDGA2) approved 613150
Muscular Dystrophy-Dystroglycanopathy (Congenital with Brain and Eye Anomalies), Type A, 3 (MDDGA3) approved 253280
Muscular Dystrophy-Dystroglycanopathy (Congenital with Brain and Eye Anomalies), Type A, 4 (MDDGA4) approved 253800
Muscular Dystrophy-Dystroglycanopathy (Congenital with Brain and Eye Anomalies), Type A, 5 (MDDGA5) approved 613153
Muscular Dystrophy-Dystroglycanopathy (Congenital with Brain and Eye Anomalies), Type A, 6 (MDDGA6) approved 613154
Muscular Dystrophy-Dystroglycanopathy (Congenital with Brain and Eye Anomalies), Type A, 7 (MDDGA7) approved 614643
Muscular Dystrophy-Dystroglycanopathy (Congenital with Brain and Eye Anomalies), Type A, 8 (MDDGA8) approved 614830
Muscular Dystrophy-Dystroglycanopathy (Congenital with Impaired Intellectual Development), Type B, 1 (MDDGB1) approved 613155
Muscular Dystrophy-Dystroglycanopathy (Congenital with Impaired Intellectual Development), Type B, 14 (MDDGB14) approved 615351
Muscular Dystrophy-Dystroglycanopathy (Congenital with Impaired Intellectual Development), Type B, 2 (MDDGB2) approved 613156
Muscular Dystrophy-Dystroglycanopathy (Congenital with Impaired Intellectual Development), Type B, 3 (MDDGB3) approved 613151
Muscular Dystrophy-Dystroglycanopathy (Congenital with Impaired Intellectual Development), Type B, 6 (MDDGB6) approved 608840